The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery

Fulya G Akkucuk1, Meral Kanbak, Banu Ayhan

  • 1Department of Anesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Renal Failure
|December 12, 2012
PubMed

Insights

Hydroxyethyl starch (HES) did not negatively impact renal function in pediatric cardiac surgery patients. This fluid can be safely used as a priming solution during cardiopulmonary bypass, showing no adverse effects on kidney function.

Area of Science:

  • Pediatric Cardiac Surgery
  • Nephrology
  • Anesthesiology

Background:

  • Limited data exists on hydroxyethyl starch (HES) use in pediatric patients.
  • Assessing renal function effects of HES versus Ringer's lactate (RL) as a priming solution in pediatric cardiac surgery is crucial.

Purpose of the Study:

  • To evaluate the safety and efficacy of hydroxyethyl starch (HES) (130/0.4) as a cardiopulmonary bypass (CPB) priming solution in pediatric patients.
  • To compare the effects of HES and Ringer's lactate (RL) on renal function markers in children undergoing cardiac surgery.

Main Methods:

  • A prospective, randomized study involving 24 pediatric patients undergoing cardiac surgery.
  • Patients received either RL (Group I) or HES (130/0.4) (Group II) as the CPB priming solution.
  • Renal function markers including serum creatinine, BUN, β2-microglobulin, cystatin C, and urinary albumin/creatinine ratio were monitored at multiple time points.

Main Results:

  • No significant differences were observed between HES and RL groups in cystatin C, β2-microglobulin, FENa, urine albumin/creatinine ratio, creatinine clearance, fluid balance, or urine output.
  • While creatinine clearance increased in the RL group, it remained stable in the HES group.
  • Urine albumin/creatinine ratio increased post-CPB in the HES group and during CPB in the RL group, with no overall group difference.

Conclusions:

  • Hydroxyethyl starch (HES) (130/0.4) can be safely administered as a priming solution in pediatric patients undergoing cardiac surgery.
  • HES did not demonstrate negative effects on renal function in this pediatric cohort.
  • The study supports the use of HES as an alternative priming solution in pediatric cardiac surgery.
Abstract

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...